Explore the complete record of transactions filed by Yea Christopher, Chief Development Officer. Insider active across 1 company, notably KalVista Pharmaceuticals, Inc.. Cumulatively, 32 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €846k. History available since 3 May 2021. The latest transaction was filed on 20 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Yea Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Yea Christopher is Chief Development Officer at KalVista Pharmaceuticals, Inc. He has 32 filings in total, and across the 32 sampled filings from 2021-05-06 to 2026-02-24, the recorded activity is entirely sales, totaling EUR 845853, with the modal transaction nature listed as Levée d'options.